Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023
Authors:
- Ryu Kyung KimRKRyu Kyung Kim
- Young June ChoeYCYoung June Choe
- Eun Jung JangEJEun Jung Jang
- Chungman ChaeCCChungman Chae
- Ji Hae HwangJHJi Hae Hwang
- Kil Hun LeeKLKil Hun Lee
- Ji Ae ShimJSJi Ae Shim
- Geun-Yong KwonGKGeun-Yong Kwon
- Jae Young LeeJLJae Young Lee
- Young-Joon ParkYPYoung-Joon Park
- Sang Won LeeSLSang Won Lee
- Donghyok KwonDKDonghyok Kwon
Open Access
- 1 January 2023
- journal article
- research article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (46) , e396
Abstract
Kim RK, et al. J Korean Med Sci. 2023 Nov;38:e396. https://doi.org/10.3346/jkms.2023.38.e396Keywords
This publication has 14 references indexed in Scilit:
- BNT162b2 Vaccine Effectiveness Against the SARS-CoV-2 Omicron Variant in Children Aged 5 to 11 YearsJAMA Pediatrics, 2023
- Humoral immune evasion of the omicron subvariants BQ.1.1 and XBBThe Lancet Infectious Diseases, 2022
- Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022MMWR. Morbidity and Mortality Weekly Report, 2022
- Neutralization of Omicron Subvariant BA.2.75 after Bivalent VaccinationNew England Journal of Medicine, 2022
- Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility ResidentsEmerging Infectious Diseases, 2022
- The Omicron Variant of the Sars-Cov-2 Virus As the Dominant Agent of a New Risk of Disease amid the COVID-19 PandemicHerald of the Russian Academy of Sciences, 2022
- How to cope with emerging viral diseases: lessons from South Korea's strategy for COVID-19, and collateral damage to cardiometabolic healthThe Lancet Regional Health - Western Pacific, 2022
- Impact of national Covid-19 vaccination Campaign, South KoreaVaccine, 2022
- Effectiveness of Booster mRNA Vaccines Against SARS-CoV-2 Infection in an Elderly Population, South Korea, October 2021–January 2022Clinical Infectious Diseases, 2022
- Systematic assessment of South Korea’s capabilities to control COVID-19Health Policy, 2021